Related Experiment Video
Updated: Apr 25, 2026

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
Published on: August 29, 2017
An antibody tag-team: driving neutralization through escape
Galit Alter1, Margaret E Ackerman2
1The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA 02139, USA.
Human immunodeficiency virus (HIV) mutates to evade antibodies. B cells evolve to recognize mutated HIV, leading to the development of neutralizing activity against the virus.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Human immunodeficiency virus (HIV) employs rapid mutation to evade the host immune system, specifically antibody detection.
- B cells possess the capacity for continuous evolution to adapt and restore recognition of mutating pathogens.
Purpose of the Study:
- To investigate the collaborative evolution of antibody repertoires in response to HIV immune evasion.
- To understand how B cells utilize viral immune evasion strategies to develop neutralizing activity.
Main Methods:
- Analysis of antibody repertoires in HIV-infected individuals.
- Tracking viral evolution and immune evasion mechanisms.
- Investigating B cell adaptive responses and antibody diversification.
Main Results:
- Antibody repertoires demonstrated stochastic collaboration in shaping the viral swarm.
- B cell evolution successfully restored recognition of mutated HIV variants.
- A subset of infected individuals developed potent neutralizing antibody activity.
Conclusions:
- The dynamic interplay between HIV mutation and B cell evolution is crucial for controlling viral infection.
- Viral immune evasion strategies can be serendipitously exploited by the host immune system to generate broadly neutralizing antibodies.
More Related Videos
07:52Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
Related Concept Videos
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Affinity and Avidity
Humoral Immune Responses
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Cross-reactivity
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...